Australia is rapidly evolving beyond its reputation as a destination for early-stage clinical trials to build a more com...
India-based Innvolution Healthcare, which develops interventional cardiology technologies and cardiac catheterisation la...
Adneuris Therapeutics, a wholly owned subsidiary of Tris Pharma advancing a new kind of pain medicine, has entered ...
UK-based Optellum and South Korea's Coreline Soft have announced their intent to collaborate across geographie...
German technology consulting and IT services company adesso SE and Japan-based Hitachi Digital Services have announ...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced the completion of Olink Explore HT pro...
Innovent Biologics, Inc. and Daiichi Sankyo have entered into an exclusive agreement for the commercialisation of Vanfly...
Bristol Myers Squibb (BMS) has announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-...
Japan-based Chugai Pharmaceutical and the University of California, San Francisco (UCSF) have entere...
Australian medical robotics company Vexev has raised $6 million in new funding to accelerate the path to FDA 5...
Merck, a leading science and technology company, is expanding its Singapore lab to further strengthen analytical and bio...
CSPC Pharmaceutical Group has entered into a contract with AstraZeneca in relation to the establishment of a joint ...
AuctuCel, a Singapore-based biotechnology company specialising in AI-powered bioprocess technologies, has announced the ...
BIOSPECTRUM ASIA | EARNINGS ALERTS +35.2% 10.7 pt -15% EUR 0.15 Celltrion r...
Northwest Biotherapeutics, a US-based biotechnology company developing DCVax® personalised immune therapies for soli...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is collaborating with Hilleman Laboratories, a Singa...
Moderna, Inc. has announced that the US Food and Drug Administration (FDA) has approved mFLUSIVA® (mRNA-1010), a new...
Energenesis Biomedical has entered into a joint development agreement with Taiwan Tanabe Seiyaku, the wholly owned ...
For decades, cancer treatment has largely focused on finding a single breakthrough therapy capable o...
Alteogen Inc., a South Korea-based biopharmaceutical company specialising in platform technologies, has entered into an ...
On 29 September, the second compliance date under Proclamation 11020 arrives. From that moment, every pharmaceutical imp...
AsymBio, a China-based biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of ...
South Korea-based Ainex Corporation, a medical AI company specialising in gastrointestinal endoscopy, has signed an agre...
Fujifilm Corporation and Taiho Pharmaceutical have entered into a strategic partnership agreement for the development of...
CREATE Medicines, Inc., a US-based clinical-stage biotechnology company pioneering in vivo immune programming, has annou...
